Integra Lifesciences Holdings $1.65B Debt Financing with Bank of America, N.A.
Integra LifeSciences completed a comprehensive refinancing of its debt, entering into a new $1.65 billion amended and restated credit agreement and issuing $450 million in 9.500% senior secured notes due 2033. The credit facility includes a $600 million revolver, a $600 million Term Loan A, and a $450 million Term Loan B. Proceeds were used to refinance the company's existing credit facility and pay related fees.
- Value
- $1.65B
- Counterparty
- Bank of America, N.A.
- Term
- 5-7 years